We have observed
14 EP applications
Céline Hélène Rouquayrol
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after June 30, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
FORMULATIONS COMPRISING 2 -AMINO- 2- [2- (4 - OCTYLPHENYL) ETHYL]PROPANE -1, 3 - DIOL
WASH SOLUTION AND METHOD FOR AFFINITY CHROMATOGRAPHY
COMBINATIONS COMPRISING A S1P RECEPTOR MODULATOR
METHOD OF TREATING VISION DISORDERS
Solid oral composition comprising a S1P receptor agonist and a sugar alcohol
S1P receptor modulators for treating multiple sclerosis
Compositions comprising sphingosine 1 phosphate (S1P) receptor modulators
Combinations comprising MGLUR modulators for the treatment of parkinson's disease
Compound formulations of 2-amino-1,3-propanediol compounds
USE OF A VEGF ANTAGONIST IN TREATING OCULAR VASCULAR PROLIFERATIVE DISEASES
PHARMACEUTICAL PRODUCTS AND STABLE LIQUID COMPOSITIONS OF IL-17 ANTIBODIES
SELECTIVE REDUCTION OF CYSTEINE RESIDUES IN IL-17 ANTIBODIES
METHODS OF TREATING PSORIASIS USING IL-17 ANTAGONISTS